Komodo launches self-service app for pharma research

Komodo Health has launched MapView, a pioneering self-service solution aimed at accelerating patient cohort analysis and insight generation within the healthcare industry. This innovative tool, part of the MapLab platform, is designed to empower users without extensive data science expertise to extract valuable insights from Komodo's Healthcare Map efficiently. By automating the generation of insights through pre-designed templates tailored to industry needs, MapView facilitates real-time analysis of disease trends, treatment paths, patient demographics, and more, thereby expediting decision-making across various stages of the Life Sciences product life cycle.

One of MapView's notable features is its ability to provide swift and comprehensive analysis, enabling users to examine the sequence and timing of events throughout the patient journey, from diagnosis to treatment. A recent analysis conducted by Komodo using MapView to explore the treatment landscape for multiple sclerosis (MS) patients highlighted previously unknown patterns in MS treatment. This underscores MapView's potential to not only aid patients and healthcare providers in making more informed decisions but also to enable Life Sciences firms to pinpoint populations that could benefit from transformative therapies.

MapLab, as the integrated suite of applications housing MapView, stands out as a comprehensive solution for streamlining the insight generation process. By offering pre-designed dashboards, customisable data analytics workflows, advanced data science capabilities, and modelling tools, MapLab empowers companies to leverage real-world data (RWD) efficiently. Web Sun, President and Co-Founder of Komodo Health, emphasises that MapLab represents a significant shift away from costly and time-intensive analytics projects, offering a unified platform that drives critical business decisions across the entirety of the enterprise.